Mainz Biomed B.V.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mainz Biomed B.V. generated cash of -$21,938,845, which is less than the previous year. Cash used in financing activities reached the amount of $14,226,692 last year. Net change in cash is therefore -$10,070,850.

Cash Flow

Mainz Biomed B.V. (NASDAQ:MYNZ): Cash Flow
2019 -416.49K 0 423.99K
2020 -468.73K -9.68K 396.68K
2021 -3.22M 1.20M 10.61M
2022 -14.76M -658.48K 23.94M
2023 -21.93M -1.89M 14.22M

MYNZ Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
17.14M8.72M122.56K203.58K229.53K
Operating activities
Net income
-26.29M-26.38M-11.69M-586.89K-957.05K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
866.41K379.79K69.92K60.46K53.04K
Stock-based compensation expense
4.00M9.82M6.43M00
Deferred income tax benefit 4.00M9.82M6.43M00
Changes in operating assets and liabilities:
Accounts receivable, net
15.54K-211.23K24.21K-99.15K339.62K
Inventories
-500.18K-172.37K-670.72M-160.47K0
Accounts payable
720.23K1.82B670.72M160.47K0
Cash generated by operating activities
-21.93M-14.76M-3.22M-468.73K-416.49K
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-1.19M-658.48K-16.70K-9.68K0
Acquisitions Net
001.21M00
Cash generated by investing activities
-1.89M-658.48K1.20M-9.68K0
Financing activities
Common Stock Issued
6.39M23.86M10.42M00
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
7.83M-197.94K-61.24K-38.87K423.99K
Cash used in financing activities
14.22M23.94M10.61M396.68K423.99K
Net Change In Cash
-10.07M8.41M8.60M-81.02K-25.94K
Cash at end of period
7.07M17.14M8.72M122.56K203.58K
Data sourceData sourceData source